News
11hon MSN
Missing messenger RNA fragments could be key to new immunotherapy for hard-to-treat brain tumors
A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that ...
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
14h
ZME Science on MSNSome People Are Immune to All Viruses. Scientists Now Want To Replicate This Ability for a Universal Antiviral
Fifteen years ago, immunologist Dusan Bogunovic stumbled across a handful of patients whose bodies played by different rules.
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that are missing in pediatric high-grade glioma tumors but not in normal brain ...
Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...
The rest of the world is not following the US government’s dangerous path, and will stick with the technology that helped the ...
Messenger RNA vaccines have proven to be effective and are safer than standard vaccines, because they have fewer side effects ...
3don MSN
Pressing pause on DNA transcription: Imaging technique reveals what happens at the atomic level
A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...
The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...
A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results